LONSURF (Taiho Pharmaceutical Co., Ltd.)
Welcome to the PulseAid listing for the LONSURF drug offered from Taiho Pharmaceutical Co., Ltd.. This Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC],Nucleoside Metabolic Inhibitor [EPC],Nucleic Acid Synthesis Inhibitors [MoA],Thymidine Phosphorylase Inhibitor [EPC],Thymidine Phosphorylase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Taiho Pharmaceutical Co., Ltd. |
| NON-PROPRIETARY NAME: | trifluridine and tipiracil |
| SUBSTANCE NAME: | TRIFLURIDINE; TIPIRACIL HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC],Nucleoside Metabolic Inhibitor [EPC],Nucleic Acid Synthesis Inhibitors [MoA],Thymidine Phosphorylase Inhibitor [EPC],Thymidine Phosphorylase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-09-22 |
| END MARKETING DATE: | 0000-00-00 |
LONSURF HUMAN PRESCRIPTION DRUG Details:
| Item Description | LONSURF from Taiho Pharmaceutical Co., Ltd. |
| LABELER NAME: | Taiho Pharmaceutical Co., Ltd. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20; 8.19(mg/1; mg/1) |
| START MARKETING DATE: | 2015-09-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 64842-1020_89fdcc48-8005-487d-828d-93d9ecb94f76 |
| PRODUCT NDC: | 64842-1020 |
| APPLICATION NUMBER: | NDA207981 |
Other TRIFLURIDINE; TIPIRACIL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
